Your browser doesn't support javascript.
loading
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
Berk, Michael; Mohebbi, Mohammadreza; Dean, Olivia M; Cotton, Sue M; Chanen, Andrew M; Dodd, Seetal; Ratheesh, Aswin; Amminger, G Paul; Phelan, Mark; Weller, Amber; Mackinnon, Andrew; Giorlando, Francesco; Baird, Shelley; Incerti, Lisa; Brodie, Rachel E; Ferguson, Natalie O; Rice, Simon; Schäfer, Miriam R; Mullen, Edward; Hetrick, Sarah; Kerr, Melissa; Harrigan, Susy M; Quinn, Amelia L; Mazza, Catherine; McGorry, Patrick; Davey, Christopher G.
Affiliation
  • Berk M; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia. michael.berk@deakin.edu.au.
  • Mohebbi M; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia. michael.berk@deakin.edu.au.
  • Dean OM; The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Australia. michael.berk@deakin.edu.au.
  • Cotton SM; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia. michael.berk@deakin.edu.au.
  • Chanen AM; Department of Psychiatry, University of Melbourne, Parkville, Australia. michael.berk@deakin.edu.au.
  • Dodd S; Barwon Health, PO Box 281, Geelong, Victoria, 3220, Australia. michael.berk@deakin.edu.au.
  • Ratheesh A; The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Australia.
  • Amminger GP; Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia.
  • Phelan M; The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Australia.
  • Weller A; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.
  • Mackinnon A; Barwon Health, PO Box 281, Geelong, Victoria, 3220, Australia.
  • Giorlando F; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
  • Baird S; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
  • Incerti L; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
  • Brodie RE; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
  • Ferguson NO; Orygen Youth Health, Northwestern Mental Health, Melbourne, Australia.
  • Rice S; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
  • Schäfer MR; The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Australia.
  • Mullen E; Department of Psychiatry, University of Melbourne, Parkville, Australia.
  • Hetrick S; Barwon Health, PO Box 281, Geelong, Victoria, 3220, Australia.
  • Kerr M; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
  • Harrigan SM; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
  • Quinn AL; Orygen Youth Health, Northwestern Mental Health, Melbourne, Australia.
  • Mazza C; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
  • McGorry P; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
  • Davey CG; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
BMC Med ; 18(1): 16, 2020 01 17.
Article in En | MEDLINE | ID: mdl-31948461
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Aspirin / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Depressive Disorder, Major / Anti-Inflammatory Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: BMC Med Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Aspirin / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Depressive Disorder, Major / Anti-Inflammatory Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: BMC Med Year: 2020 Document type: Article